BiotechTube
Home/Zata Pharmaceuticals/Ivan Yanachkov, PhD
IY

Ivan Yanachkov, PhD

Chief Scientific Officer

Zata Pharmaceuticals

Therapeutic Areas

CardiovascularInfectious DiseaseGenetic Disorders

Zata Pharmaceuticals Pipeline

DrugIndicationPhase
GLS409Acute Coronary Syndrome (Heart Attack)Pre-clinical
ZON PlatformUndisclosed (Anti-pathogen, potential genetic disorders)Research/Pre-clinical

Leadership Team at Zata Pharmaceuticals

DT
David Tabatadze, PhD
President & CEO
View full Zata Pharmaceuticals profile